Endogenous Type I CRISPR-Cas: From Foreign DNA Defense to Prokaryotic Engineering.
Zheng Y, Li J, Wang B, Han J, Hao Y, Wang S, Ma X, Yang S, Ma L, Yi L, Peng W.
Zheng Y, et al. Among authors: peng w.
Front Bioeng Biotechnol. 2020 Mar 4;8:62. doi: 10.3389/fbioe.2020.00062. eCollection 2020.
Front Bioeng Biotechnol. 2020.
PMID: 32195227
Free PMC article.
Review.